RYAN RUNYON: Open Payments
NPI 1932115938 · PRINCETON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 133 payments from 18 companies in 2025. Trend: 2023 $1,900 · 2024 $1,773 · 2025 $2,010
Food & beverage: $2,010
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $308 |
| Amgen Inc. | 21 | $262 |
| Kowa Pharmaceuticals America, Inc. | 23 | $242 |
| ABBVIE INC. | 18 | $226 |
| Novo Nordisk Inc | 12 | $220 |
| Lilly USA, LLC | 8 | $161 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $141 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $134 |
| PFIZER INC. | 4 | $62 |
| GlaxoSmithKline, LLC. | 4 | $61 |
Products named: ZORYVE, JARDIANCE, OTEZLA, FARXIGA, AIRSUPRA, MOUNJARO, Ozempic, XIFAXAN.
Industry payments across WV — which companies pay providers there.
